Income Statement (TTM)
Onco-Innovations Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2025 04-30 |
|
|---|---|
| Revenue | 0 |
| Change (%) | |
| % of Revenue | 100.00 |
| Cost Of Sales | |
| Change (%) | |
| % of Revenue | |
| Gross Operating Profit | 0 |
| Change (%) | |
| % of Revenue | 100.00 |
| SG&A | 3 |
| Change (%) | |
| % of Revenue | 4,431.15 |
| R&D | 0 |
| Change (%) | |
| % of Revenue | 371.11 |
| OpEx | 3 |
| Change (%) | |
| % of Revenue | 4,802.26 |
| Operating Income | -3 |
| Change (%) | |
| % of Revenue | -4,702.26 |
| Interest Expense | |
| Change (%) | |
| % of Revenue | |
| Net Income | -8 |
| Change (%) | |
| % of Revenue | -13,010.36 |
Source: Capital IQ
